Induction with Either Alemtuzumab, r-ATG or Basilixima Associated with Similar Outcomes in Kidney Transplant Recipients on Rapid Steroid Withdrawal.

被引：0
|
作者：
Reddy, K. S. [3 ]
Nijim, S. [1 ]
Chakker, H. [1 ]
Hamawi, K. [1 ]
Williams, J. [2 ]
Moss, A. [3 ]
Mulligan, D. [3 ]
Heilman, R. [1 ]
机构：
[1] Mayo Clin, Dept Med, Phoenix, AZ USA
[2] Mayo Clin, Dept Pathol, Phoenix, AZ USA
[3] Mayo Clin, Dept Surg, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1414
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [1] Comparison of 1-Yr Protocol Biopsy Findings in Kidney Transplant Recipients on Rapid Steroid Withdrawal (RSW) Getting Induction with Either Alemtuzumab (Alem), Rabbit-Antithymocyte Globulin (r-ATG) or Basiliximab (Bas).
    Heilman, R.
    Nijim, S.
    Chakkera, H.
    Hamawi, K.
    Williams, J.
    Moss, A.
    Mulligan, D.
    Reddy, K. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 442 - 443
  • [2] Early Rejection Outcomes with IL-2 vs. ATG Induction among Kidney Transplant Recipients Induction Differences with Early Steroid Withdrawal.
    Burelli, C.
    Szczepanik, A.
    Yadav, K.
    Sanchez, E.
    Debroy, M.
    Humphreville, V.
    Rabets, J.
    Padiyar, A.
    Sarabu, N.
    Jittirat, A.
    Palanisamy, A.
    Chavin, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 700 - 701
  • [3] Outcomes Associated with Steroid Avoidance and Alemtuzumab among Kidney Transplant Recipients
    Serrano, Oscar K.
    Friedmann, Patricia
    Ahsanuddin, Sayeeda
    Millan, Carlos
    Ben-Yaacov, Almog
    Kayler, Liise K.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (11): : 2030 - 2038
  • [4] Outcomes of Basiliximab and Rapid Steroid Withdrawal versus Thymoglobulin Induction in Pediatric Kidney Transplant Recipients
    Steinman, Benjamin
    Kilduff, Stella
    Hayde, Nicole
    PEDIATRIC TRANSPLANTATION, 2023, 27
  • [5] Outcomes in Elderly Black Renal Transplant Recipients Receiving Basiliximab Induction and Early Steroid Withdrawal.
    Garcia, E.
    Sparkes, T.
    Szczepanik, A.
    Bova, S.
    Bromberg, J.
    Haririan, A.
    Casale, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1085 - 1086
  • [6] Simultaneous kidney pancreas transplantation using rapid steroid taper with protocol biopsies: Comparison of r-ATG versus alemtuzumab
    Reddy, K. S.
    Moss, A.
    Heilman, R.
    Mazur, M.
    Chakkera, H.
    Mekeel, K.
    Post, D.
    Mulligan, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 553 - 554
  • [7] Outcomes Using Alemtuzumab Induction in Pediatric Kidney Transplant Recipients
    Zhang Yifeng
    Kumar, Juhi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [8] Alemtuzumab versus anti-thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen
    Rikard, Rachel A.
    Chargualaf, Laura M.
    Coulter, Carolyn
    Weimer, Eric T.
    Schmitz, John L.
    Kotzen, Elizabeth S.
    Prom, Alyson
    Toledo, Alexander H.
    Szempruch, Kristen R.
    CLINICAL TRANSPLANTATION, 2024, 38 (02)
  • [9] Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
    Hurst, Frank P.
    Altieri, Maria
    Nee, Robert
    Agodoa, Lawrence Y.
    Abbott, Kevin C.
    Jindal, Rahul M.
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 34 (06) : 534 - 541
  • [10] Rapid steroid withdrawal in high risk kidney transplant recipients.
    Dube, Geoffrey K.
    Ebcioglu, Zeynep
    Thompson, Aliza M.
    Hardy, Mark A.
    Ratner, Lloyd E.
    Cohen, David J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 447 - 447
12345